Inotrem CEO Sven Zimmermann (L) and head of scientific and medical affairs Jean-Jacques Garaud
Inotrem’s septic shock drug passes mid-stage test — but only for some patients
Roche vet Jean-Jacques Garaud co-founded Inotrem in 2013, bringing an international syndicate of investors to the biotech headquartered in his native Paris. Inotrem’s focus …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
